Navigation Links
Express Scripts HealthBridge Pharma & Biotech to Provide Exclusive Specialty Pharmacy Services and Limited Distribution Services for Solesta®
Date:10/13/2011

ST. LOUIS, Oct. 13, 2011 /PRNewswire/ -- CuraScript, Inc., a wholly owned subsidiary of Express Scripts, Inc., is now the exclusive specialty pharmacy for patients using Solesta®, a product of Oceana Therapeutics Inc., under an agreement announced today. Part of Express Scripts HealthBridge Pharma & Biotech services, CuraScript SD Specialty Distribution will be one of two national distributors responsible for delivering Solesta to healthcare providers.

Solesta is the only nonsurgical treatment approved by the Food and Drug Administration for patients who fail conservative therapy for fecal (bowel) incontinence. A biocompatible tissue-bulking agent, Solesta is an injectable gel administered in an outpatient setting without the need for anesthesia. Oceana Therapeutics has exclusive rights to market, sell and distribute Solesta, a registered trademark of the international medical device company Q-Med AB.

About HealthBridge Pharma & BiotechHealthBridge Pharma & Biotech provides a suite of services offering pharmaceutical and biotech companies a single solution approach to patient care. These services include: CuraScript SP Specialty Pharmacy, CuraScript SD Specialty Distribution, Freedom Fertility Pharmacy, risk evaluation and mitigation strategies (REMS), reimbursement, patient assistance programs (PAP), data and sales reporting, enhanced account services, and customized adherence programs.

As a service of HealthBridge Pharma & Biotech, CuraScript SP Specialty Pharmacy is a wholly owned subsidiary of Express Scripts. CuraScript manages the largest number of exclusive Pharma/Biotech programs in the industry and has been involved in nearly every specialty product launch over the last eight years. CuraScript services more than 1,800 plan sponsors that cover tens of millions of Americans.

CuraScript SD Specialty Distribution, an Express Scripts subsidiary, is a premier provider of comprehensive distribution solutions f
'/>"/>

SOURCE Express Scripts
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Express Scripts Announces Revised 2011 Financial Guidance
2. ChemoMetec and De Novo Software to Co-market NucleoCounter® NC-3000™ and FCS Express 4 Image Cytometry Software
3. Transcriptome Viewer - Comprehensive Genome-wide Map of Human Gene Expression Activity Released for Public by MediSapiens
4. Merger of Express Scripts and Medco Health Solutions Will Address the Bipartisan Mandate for Safer, More Affordable, Higher Quality Healthcare
5. Molecular Devices Announces ImageXpress Micro XL High-Content Screening System
6. Express Scripts to Present at Investor Conferences in September
7. Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
8. Express Scripts and Medco Health Solutions Sign Definitive Merger Agreement; Medco Shareholders to Receive $29.1 Billion
9. Express Scripts Announces Second Quarter 2011 Earnings Conference Call
10. Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families
11. Generex Announces Appointment of CEO for Post-Spinout Antigen Express
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014   , 2014 Second Quarter ... prior year , Overall organic growth was 4% for same ... products; Bausch + Lomb grew 12% , 2014 Second ... 43% , 2014 Second Quarter GAAP Operating Cash Flow ... , Highlights of the Second Quarter , Launched 17 new ...
(Date:7/31/2014)... PARK, N.C. , July 31, 2014 ... Miami facilities to meet the clinical trial ... .  The newly expanded facility will continue to ... consolidation of shipments to and from the region, and ... its newest location, Marken will combine its office and ...
(Date:7/31/2014)... , July 31, 2014 Auxilium ... a specialty biopharmaceutical company, today announced that the ... payment from its partner Asahi Kasei Pharma Corporation ... the successful submission of a regulatory application to ... for XIAFLEX ® (collagenase clostridium histolyticum) for ...
Breaking Medicine Technology:Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32Marken Expands Miami Regional Logistics Center 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4
... , BUDAPEST, Hungary , ... Pfizer Globally Licenses ChemAxon,s Platform For Markush Structure,Searching And Enumeration ... of cheminformatics software for the life,sciences industry has entered into ... functionality for global,development and deployment within Pfizer,s global R&D facilities. ...
... , , , ... The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) ... sclerosis (MS). In clinical trials, patients treated with Ampyra had ... (placebo). This is the first drug approved for this use. ...
Cached Medicine Technology:FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis 2
(Date:7/31/2014)... Care Communications, Inc., (CARE) a national health care ... Elite Award for “Recruitment, Selection and Orientation” from the ... awards presented as part of “Chicago’s 101 ... awards competition. This marks the seventh consecutive year Care ... CARE has also been chosen as a national winner ...
(Date:7/31/2014)... 31, 2014 Daily Gossip reveals in its ... sufferers discover some breakthrough weight loss tips. , The ... and recommendations are very simple to implement. Users don’t have ... with no need to start counting calories. , The ... in fact created a 12 weeks weight loss program to ...
(Date:7/31/2014)... In its latest blog post, Best ... having family close by during a stay in rehab can ... is successful, is looking at 10 tips to help drug ... recovery is a lifelong process, and one that former addicts ... without compromise,” commented Best Drug Rehabilitation’s CEO Per Wickstrom ...
(Date:7/31/2014)... 31, 2014 The study, The ... in Medicare episode of care payments for four clinical ... major joint replacements (hips and knees). Using the ... Payments for Care Improvement program, the study examines these ... regions in the country. , “Our study reaffirms that, ...
(Date:7/30/2014)... 30, 2014 The Mesothelioma ... Penn's Abramson Cancer Center, will host a regional ... experts in the field of mesothelioma. September 26 marks ... is open to the public, and specifically aimed at ... who have been exposed to asbestos. , The conference ...
Breaking Medicine News(10 mins):Health News:Care Communications, Inc. Named an Elite Award Winner Among Top Chicago Employers 2Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 2Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 3
... in five Americans,suffers from the pain of arthritis. The ... the year 2030, 67 million people in the,U.S. will ... million.,Arthritis can be a painful, life-impacting condition, but its ... such as walking, is crucial in preventing and,managing the ...
... Press announces the,release of a new book -- ... to help older people understand and proactively address ... Dr. Heather D.,Hadjistavropoulos and their contributors, this softcover ... and,simple instructions for managing persistent pain., "With ...
... More, a,national non-profit dedicated to improving the lives ... season. Invisimomibility is a,chronic, pervasive condition in which ... inability to successfully fulfill one,s,caregiving, civic and paid ... and economic risk., For decades, the unpaid ...
... 25, 2008) -- Heart failure patients at NewYork-Presbyterian Hospital/Columbia ... implanted with the HeartMate II LVAS (Left Ventricular Assist ... hearts pump blood -- that has now received approval ... use as bridge to transplantation. As part of clinical ...
... WebMD Health Corp. (Nasdaq:,WBMD) and HLTH Corporation (Nasdaq: ... scheduled to participate at the Third Annual Needham & ... 2008 at 8:00 am ET., Investors, analysts and ... audio broadcast of the presentation over the Internet. The ...
... in,Brachioplasty (arm lift) techniques will be discussed by leading ... Aesthetic Plastic Surgery,(ASAPS) being held at the San Diego ... Arm: A Treatment Algorithm" will be moderated by,Daniel Morello, ... discuss,traditional Brachioplasty; Felmont Eaves, MD, who will discuss the,procedure ...
Cached Medicine News:Health News:GET UP AND MOVE! May is Arthritis Awareness Month - The Perfect Time to Learn the Importance of Staying Active 2Health News:New Book Helps Older Adults Manage Chronic Pain 2Health News:Mothers & More Fights to End Invisimomibility 2Health News:FDA approves HeartMate II mechanical heart pump for heart-failure patients 2Health News:Current Trends in Arm Lift Surgery 2Health News:Current Trends in Arm Lift Surgery 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: